Best Medicines Coalition (BMC)

The Best Medicines Coalition (BMC) is a national alliance of Canadian patient organizations and individual patient advocates who share a commitment to ensuring safe, timely and equitable access to evidence-based medicines for all Canadians. Representing millions of patients living with or affected by chronic disease or other illnesses, the organization is engaged in a range of related policy discussions, including pharmaceutical review, reimbursement, treatment, life cycle management and safety issues.

During 2020:

  • GSK provided core funding of $20,000 for their Pharmaceutical Patient Access Advocacy Program.
  • GSK provided project funding of $25,000 for their Covid-19 Patient Community Support and Advocacy Program.

Our support represented 13.8% of their overall income.

< Back to Links